Biochemical and structural characterization of the subclass B1 metallo-β-lactamase VIM-4

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 3, 2011, Pages 1248-1255

  Lassaux, Patricia ^a   Traoré, Daouda A K ^b   Loisel, Elodie ^c   Favier, Adrien ^b,d   Docquier, Jean Denis ^e   Sohier, Jean Sébastien ^a   Laurent, Clémentine ^a   Bebrone, Carine ^a   Frère, Jean Marie ^a   Ferrer, Jean Luc ^b   Galleni, Moreno ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b INSTITUT DE BIOLOGIE STRUCTURALE   (France)

^c Laboratoire d'Ingénierie des Macromolécules LIM   (France)

^d Laboratoire de Spectrométrie de Masse des Protéines LSMP   (France)

^e UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ARGININE; BETA LACTAMASE; CEFALOTIN; HYDROLASE; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE VIM 1; METALLO BETA LACTAMASE VIM 2; METALLO BETA LACTAMASE VIM 4; NITROCEFIN; PENICILLIN G; UNCLASSIFIED DRUG; ZINC;

ARTICLE; CRYSTAL STRUCTURE; ENZYME CHEMISTRY; ENZYME STRUCTURE; ESCHERICHIA COLI; KINETICS; NONHUMAN; PRIORITY JOURNAL; THERMOSTABILITY;

AMPICILLIN; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEPHALOSPORINS; CEPHALOTHIN; CRYSTALLOGRAPHY, X-RAY; ESCHERICHIA COLI; IMIPENEM; MAGNETIC RESONANCE SPECTROSCOPY; PENICILLIN G; THIENAMYCINS;

EID: 79952324032     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01486-09     Document Type: Article

References (44)

1. Attali, C., et al. 2008. Streptococcus pneumoniae choline-binding protein E interaction with plasminogen/plasmin stimulates migration across the extracellular matrix. Infect. Immun. 76:466-476.
2. Bebrone, C. 2007. Metallo-beta-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily. Biochem. Pharmacol. 74:1686-1701.
3. Bebrone, C., et al. 2008. Mutational analysis of the zinc- and substratebinding sites in the CphA metallo-beta-lactamase from Aeromonas hydrophila. Biochem. J. 414:151-159.
4. Bebrone, C., et al. 2009. The structure of the dizinc subclass B2 metallobeta-lactamase CphA reveals that the second inhibitory zinc ion binds in the histidine site. Antimicrob. Agents Chemother. 53:4464-4471.
5. Beck, J., et al. 2009. Discovery of novel lipophilic inhibitors of OXA-10 enzyme (class D beta-lactamase) by screening amino analogs and homologs of citrate and isocitrate. Bioorg. Med. Chem. Lett. 19:3593-3597.
6. Bogaerts, P., et al. 2008. Nosocomial infections caused by multidrug-resistant Pseudomonas putida isolates producing VIM-2 and VIM-4 metallo-betalactamases. J. Antimicrob. Chemother. 61:749-751.
7. Bounaga, S., A. P. Laws, M. Galleni, and M. I. Page. 1998. The mechanism of catalysis and the inhibition of the Bacillus cereus zinc-dependent betalactamase. Biochem. J. 331(Pt 3):703-711. (Pubitemid 28211890)
8. Carfi, A., et al. 1995. The 3-D structure of a zinc metallo-beta- lactamase from Bacillus cereus reveals a new type of protein fold. EMBO J. 14:4914-4921.
9. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7th ed. Approved standard. CLSI document M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
10. Collaborative Computational Project No. 4. 1994. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. D50:760-763.
11. Cornish-Bowden, A. 2001. Fundamentals of enzyme kinetics. Portland Press Ltd., London, United Kingdom.
12. Crowder, M. W., Z. Wang, S. L. Franklin, E. P. Zovinka, and S. J. Benkovic. 1996. Characterization of the metal-binding sites of the beta-lactamase from Bacteroides fragilis. Biochemistry 35:12126-12132.
13. Docquier, J. D., et al. 2003. On functional and structural heterogeneity of VIM-type metallo-beta-lactamases. J. Antimicrob. Chemother. 51:257-266.
14. Dragani, B., et al. 1999. Unfolding and refolding of human glyoxalase II and its single-tryptophan mutants. J. Mol. Biol. 291:481-490.
15. Emsley, P., and K. Cowtan. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60:2126-2132.
16. Franceschini, N., et al. 2000. Purification and biochemical characterization of the VIM-1 metallo-beta-lactamase. Antimicrob. Agents Chemother. 44: 3003-3007.
17. Garcia-Saez, I., J. D. Docquier, G. M. Rossolini, and O. Dideberg. 2008. The three-dimensional structure of VIM-2, a Zn-beta-lactamase from Pseudomonas aeruginosa in its reduced and oxidised form. J. Mol. Biol. 375:604-611.
18. Giannouli, M., et al. 2009. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii strains in intensive care units of multiple Mediterranean hospitals. J. Antimicrob. Chemother. 63:828-830.
19. Giske, C. G., M. Rylander, and G. Kronvall. 2003. VIM-4 in a carbapenem-resistant strain of Pseudomonas aeruginosa isolated in Sweden. Antimicrob. Agents Chemother. 47:3034-3035.
20. Hernandez Valladares, M., et al. 1997. Zn(II) dependence of the Aeromonas hydrophila AE036 metallo-beta-lactamase activity and stability. Biochemistry 36:11534-11541.
21. Juan, C., et al. 2008. Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain. Antimicrob. Agents Chemother. 52:3589-3596.
22. Kabsch, W. 1993. Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. J. Appl. Crystallogr. 26:795-800.
23. Kontou, M., et al. 2007. Molecular cloning and biochemical characterization of VIM-12, a novel hybrid VIM-1/VIM-2 metallo-beta-lactamase from a Klebsiella pneumoniae clinical isolate, reveal atypical substrate specificity. Biochemistry 46:13170-13178. (Pubitemid 350086235)
24. Ktari, S., et al. 2006. Emergence of multidrug-resistant Klebsiella pneumoniae isolates producing VIM-4 metallo-beta-lactamase, CTX-M-15 extended-spectrum beta-lactamase, and CMY-4 AmpC beta-lactamase in a Tunisian university hospital. Antimicrob. Agents Chemother. 50:4198-4201.
25. Lauretti, L., et al. 1999. Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Agents Chemother. 43:1584-1590.
26. Libisch, B., et al. 2004. Isolation of an integron-borne blaVIM-4 type metallo-beta-lactamase gene from a carbapenem-resistant Pseudomonas aeruginosa clinical isolate in Hungary. Antimicrob. Agents Chemother. 48:3576-3578.
27. Libisch, B., et al. 2006. Molecular epidemiology of VIM-4 metallo-beta-lactamase-producing Pseudomonas sp. isolates in Hungary. Antimicrob. Agents Chemother. 50:4220-4223.
28. Luzzaro, F., et al. 2004. Emergence in Klebsiella pneumoniae and Enterobacter cloacae clinical isolates of the VIM-4 metallo-beta-lactamase encoded by a conjugative plasmid. Antimicrob. Agents Chemother. 48:648-650.
29. Matagne, A., J. Lamotte-Brasseur, and J. M. Frere. 1993. Interactions between active-site serine beta-lactamases and so-called beta-lactamase-stable antibiotics. Kinetic and molecular modelling studies. Eur. J. Biochem. 217:61-67.
30. Matagne, A., et al. 1990. The diversity of the catalytic properties of class A beta-lactamases. Biochem. J. 265:131-146. (Pubitemid 20037683)
31. Materon, I. C., Z. Beharry, W. Huang, C. Perez, and T. Palzkill. 2004. Analysis of the context dependent sequence requirements of active site residues in the metallo-beta-lactamase IMP-1. J. Mol. Biol. 344:653-663.
32. McCoy, A. J. 2007. Solving structures of protein complexes by molecular replacement with Phaser. Acta Crystallogr. D Biol. Crystallogr. 63:32-41.
33. Patzer, J., et al. 2004. Pseudomonas aeruginosa strains harbouring an unusual blaVIM-4 gene cassette isolated from hospitalized children in Poland (1998-2001). J. Antimicrob. Chemother. 53:451-456.
34. Peleg, A. Y., J. M. Bell, A. Hofmeyr, and P. Wiese. 2006. Inter-country transfer of Gram-negative organisms carrying the VIM-4 and OXA-58 carbapenem-hydrolysing enzymes. J. Antimicrob. Chemother. 57:794-795.
35. Pournaras, S., et al. 2003. Hospital outbreak of multiple clones of Pseudomonas aeruginosa carrying the unrelated metallo-beta-lactamase gene variants blaVIM-2 and blaVIM-4. J. Antimicrob. Chemother. 51:1409-1414.
36. Pournaras, S., A. Tsakris, M. Maniati, L. S. Tzouvelekis, and A. N. Maniatis. 2002. Novel variant (bla(VIM-4)) of the metallo-beta-lactamase gene bla(VIM-1) in a clinical strain of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 46:4026-4028.
37. Prosperi-Meys, C., et al. 1999. Interaction between class B beta-lactamases and suicide substrates of active-site serine beta-lactamases. FEBS Lett. 443:109-111. (Pubitemid 29078612)
38. Robin, F., N. Aggoune-Khinache, J. Delmas, M. Naim, and R. Bonnet. 2010. Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria. Antimicrob. Agents Chemother. 54:466-470.
39. Rodriguez-Martinez, J. M., P. Nordmann, N. Fortineau, and L. Poirel. 2010. VIM-19, a metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae. Antimicrob. Agents Chemother. 54:471-476.
40. Sabath, L. D., and E. P. Abraham. 1966. Zinc as a cofactor for cephalosporinase from Bacillus cereus 569. Biochem. J. 98:11C-3C.
41. Schanda, P., V. Forge, and B. Brutscher. 2006. HET-SOFAST NMR for fast detection of structural compactness and heterogeneity along polypeptide chains. Magn. Reson. Chem. 44(Spec. No.):S177-S184.
42. Studier, F. W. 2005. Protein production by auto-induction in high density shaking cultures. Protein Expr. Purif. 41:207-234.
43. Toleman, M. A., K. Rolston, R. N. Jones, and T. R. Walsh. 2004. blaVIM-7, an evolutionarily distinct metallo-beta-lactamase gene in a Pseudomonas aeruginosa isolate from the United States. Antimicrob. Agents Chemother. 48:329-332.
44. Yamaguchi, Y., et al. 2007. Crystallographic investigation of the inhibition mode of a VIM-2 metallo-beta-lactamase from Pseudomonas aeruginosa by a mercaptocarboxylate inhibitor. J. Med. Chem. 50:6647-6653.